Overview

Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

Status:
RECRUITING

Trial end date:
2030-01-05

Target enrollment:

Participant gender:

Summary

This is an open-label, prospective, randomized, Phase III, international multicenter clinical study to compare radiotherapy plus nimotuzumab versus radiotherapy alone in platinum-ineligible patients with locoregionally advanced head and neck squamous cell carcinoma (LA-HNSCC),

Phase:

PHASE3

Details

Lead Sponsor:

Shandong Cancer Hospital and Institute

Treatments:

nimotuzumab